封面
市场调查报告书
商品编码
1084760

冷冻干燥药的市场规模、占有率、趋势、预测 (2022年~2028年):各药物类别、适应症、包装类型、地区

Lyophilized Drugs Market, by Drug Class, by Indication, by Packaging Type, and by region - Size, Share, Trends, and Forecast, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3个工作天内

价格
简介目录

感染疾病的流行增加,有助于全球冷冻干燥药市场成长。还有製造商积极扩张冷冻干燥剂的大规模製造设备,对该市场的成长也有贡献。

本报告提供全球冷冻干燥药的市场调查,市场定义和概要,市场成长的各种影响因素分析,法律制度,技术趋势,市场规模的变化、预测,各种区分、各地区/主要国家的明细,竞争环境,主要企业简介等彙整资讯。

目录

第1章 调查目的、前提条件

第2章 市场概要

第3章 市场动态、法律规章、趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要的展开
  • 技术的进步
  • 历史概要
  • M&A
  • 法规情境
  • 波特分析
  • PEST分析

第4章 全球冷冻干燥药市场:各类药物

  • 抗感染药
  • 抗肿瘤剂
  • 利尿剂
  • 质子帮浦抑制剂
  • 麻醉剂
  • 抗凝固剂
  • NSAID
  • 其他

第5章 全球冷冻干燥药市场:各适应症

  • 感染疾病
  • 自体免疫疾病
  • 肠胃疾病
  • 癌症
  • 其他

第6章 全球冷冻干燥药市场:各包装形式

  • 管瓶
  • 注射器
  • 滤芯

第7章 全球冷冻干燥药市场:各地区

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东
  • 非洲

第8章 竞争情形

  • 热图分析
  • 企业简介
    • Sanofi SA
    • Merck &Co., Inc.
    • Fresenius Kabi USA, LLC.
    • Ciron Drugs &Pharmaceuticals Pvt Ltd.
    • GlaxoSmithKline plc.
    • Mylan NV.
    • Pfizer, Inc.
    • Amneal Pharmaceuticals LLC
    • Otsuka Holdings Co., Ltd.(Otsuka Pharmaceutical Co., Ltd.)
    • BTG Plc.
  • 分析师的见解

第9章 Section

简介目录
Product Code: CMI2930

Lyophilization or freeze drying is the process, in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: Freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient (API), protein, collagen, peptide, oligonucleotide, enzymes, and mAbs.

Market Dynamics

Lyophilized drugs are majorly used to treat infectious diseases and autoimmune diseases. Thus, increasing prevalence of infectious diseases is expected to aid in growth of the global lyophilized drugs market. For instance, according to The Lancet Infectious Diseases (report) published in 2021, fungal infection affects over a billion people worldwide, resulting in around 11.5 million life-threatening infections and over 1.5 million deaths, annually. The number of lyophilized drugs such as Amphotericin B (Mycoflu), Vonfung NDD (voriconazole,) and other antifungal lyophilized drugs are available in market for treating fungal infections.

Lyophilized drug manufacturers are looking forward to expand their facilities to produce lyophilized drugs on large scale, which in turn contributing to growth of the global lyophilized drugs market. For instance, on January 2021, AB Technologies (AB) announced investment of US$ 10.5 million to build a new 23,000-square-foot manufacturing facility at its site in Bloomington, Indiana. The new facility will include manufacturing area for formulating, filling, lyophilizing, and packaging drugs for early-phase clinical trial studies. Moreover, AB Technologies (AB) added aseptic filling and lyophilizer loading systems into the new facility.

Major pharmaceutical manufacturers are engaged in the development and launching of innovative lyophilized drugs, which is expected to drive the global lyophilized drugs market growth. For instance, in November 2018, Xellia Pharmaceuticals launched Vancomycin Hydrochloride for Injection, USP within the U.S. market. Vancomycin Hydrochloride for Injection is lyophilized powder to treat or prevent infections that are caused by bacteria

Key features of the study:

  • This report provides in-depth analysis of the global lyophilized drugs market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2022-2028), considering 2021, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global lyophilized drugs market based on the following parameters - company overview, financial performance, Technology portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Sanofi S.A, Merck & Co., Inc., Fresenius Kabi USA, LLC., Ciron Drugs & Pharmaceuticals Pvt Ltd., GlaxoSmithKline plc., Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.), and BTG Plc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future technology launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global lyophilized drugs market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global Lyophilized Drugs Market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Lyophilized Drugs Market, By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
  • Global Lyophilized Drugs Market, By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
  • Global Lyophilized Drugs Market, By Packaging Type:
    • Vial
    • Injection
    • Cartridge
  • Global Lyophilized Drugs Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Middle East
      • By Country/Region:
    • GCC
    • Israel
    • Rest of Middle East
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
  • Company Profiles
    • Sanofi S.A *
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Merck & Co., Inc.
    • Fresenius Kabi USA, LLC.
    • Ciron Drugs & Pharmaceuticals Pvt Ltd.
    • GlaxoSmithKline plc.
    • Mylan NV.
    • Pfizer, Inc.
    • Amneal Pharmaceuticals LLC
    • Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
    • BTG Plc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Indication
    • Market Snippet, By Packaging Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Lyophilized Drugs Market, By Drug Class, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Anti-infective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Antineoplastic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Diuretics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Proton Pump Inhibitor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Anesthetic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Anticoagulant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • NSAID's
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Lyophilized Drugs Market, By Indication, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Infectious Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Autoimmune Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Gastrointestinal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Lyophilized Drugs Market, By Packaging Type, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Vials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Cartridge
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Lyophilized Drugs Market, By Region, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Sanofi S.A.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fresenius Kabi USA, LLC.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Ciron Drugs & Pharmaceuticals Pvt Ltd.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Mylan NV.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer, Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Amneal Pharmaceuticals LLC
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BTG Plc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact